These finding showed that substantial alterations in the expression of Noxa or Puma without any other treatments can also exhibit significant anti-tumor effects and thus offers new insights that, could be relevant to the field of liver cancer drug development. This evidence concerns the gene PMAIP1 and liver cancer.